# Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/adalimumab-for-prevention-of-uveitic-flare-in-patients-with-inactive-non/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Quan Dong Nguyen,Pauline T. Merrill,Glenn J. Jaffe,Andrew D. Dick,Shree K. Kurup,John D. Sheppard,Ariel Schlaen,Carlos Pavésio,Luca Cimino,Joachim Van Calster,Anne Camez,Nisha V. Kwatra,Alexandra Song,Martina Kron,Samir Tari,Antoine P. Brézin |
| Citations | 516 |
| DOI | 10.1016/s0140-6736(16)31339-3 |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://research-information.bris.ac.uk/ws/files/90335840/VISUAL_II_Lancet_MS_resubmission_Final_2nd_Review_07112016.pdf |
| OpenAlex ID | https://openalex.org/W2510021462 |
| PMID | 27542302 |
| Type | article |
| Year | 2016 |

## Paper authors

- [Carlos Pavésio](https://scholariq.org/researchers/carlos-pavesio/)

## Paper journal

- [The Lancet](https://scholariq.org/journals/the-lancet/)

## Paper primary topic

- [Ocular Diseases and Behçet’s Syndrome](https://scholariq.org/topics/ocular-diseases-and-behcet-s-syndrome/)

## Paper topics

- [Ocular Diseases and Behçet’s Syndrome](https://scholariq.org/topics/ocular-diseases-and-behcet-s-syndrome/)
- [Sarcoidosis and Beryllium Toxicity Research](https://scholariq.org/topics/sarcoidosis-and-beryllium-toxicity-research/)
- [CNS Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/cns-lymphoma-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.